Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Total 13F shares
-
105,032,153
-
Share change
-
+1,065,959
-
Total reported value
-
$660,602,362
-
Put/Call ratio
-
324%
-
Price per share
-
$6.29
-
Number of holders
-
103
-
Value change
-
+$7,244,092
-
Number of buys
-
38
-
Number of sells
-
45
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2019
As of 30 Jun 2019,
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,032,153 shares.
The largest 10 holders included
Artal Group S.A., FMR LLC, Ulys, L.L.C., VANGUARD GROUP INC, BlackRock Inc., FIRST MANHATTAN CO, NEA Management Company, LLC, Opaleye Management Inc., Clearbridge Investments, LLC, and UBS ASSET MANAGEMENT AMERICAS INC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.